EverydayHealthLogo
Dr. Laura Bachrach, MD

Dr. Laura Bachrach, MD

Palo Alto, CA

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Bachrach, Pediatric Endocrinologist in Palo Alto, CA?

    Dr. Laura Bachrach, MD is a Pediatric Endocrinologist, who primarily practices in Palo Alto, CA with 1 additional practice location. She is board certified by the American Board of Pediatrics. Dr. Bachrach completed her residency at Stanford Univ Hosp, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics. Dr. Bachrach is fluent in English and Spanish, and is currently seeing new patients. Dr. Bachrach’s practice accepts Kaiser Permanente, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Bachrach’s office at (408) 885-5000.

    What are Areas of Expertise for Dr. Bachrach?

    Dr. Laura Bachrach, MD is a highly-rated, board-certified Pediatric Endocrinologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Bachrach empowers patients to confidently navigate their health journey, specializing in Diabetes, or comprehensive wellness support. Serving the Palo Alto/CA community, Dr. Bachrach is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Bachrach go to medical school and complete their residency?

    • Residency: Stanford Univ Hosp, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics

    • Medical School: Tufts Univ Sch of Med, Boston Ma

    Is Dr. Bachrach board certified in Pediatric Endocrinologist?

    Yes, Dr. Laura Bachrach, MD is board certified by the American Board of Pediatrics

    What languages does Dr. Bachrach speak?

    Dr. Bachrach and their clinical team can communicate with patients in the following languages:

    • English

    • Spanish

    What conditions does Dr. Bachrach treat?

    As a Pediatric Endocrinologist, Dr. Bachrach diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Bachrach. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Congenital Hypothyroidism
    • Other Hypothyroidism
    • Hypothyroidism
    • Post-Surgery Hypothyroidism
    • Congenital hypothyroidism
    • Hypothyroidism (Underactive Thyroid)
    • Underactive Thyroid at Birth
    • Neonatal Hypothyroidism
    • Underactive Thyroid
    • Low Thyroid Function
    • Thyroid Gland Underactivity
    • Postoperative Underactive Thyroid
    • Thyroid Failure After Surgery

    ICD-10 Codes:

    • E031: Congenital hypothyroidism without goiter
    • E038: Other specified hypothyroidism
    • E039: Hypothyroidism, unspecified
    • E890: Postprocedural hypothyroidism

    Also known as:

    • Short Stature in Children
    • Growth Disorder
    • Child Growth Problems
    • Dwarfism
    • Growth Retardation

    ICD-10 Codes:

    • R6252: Short stature (child)

    Also known as:

    • Early Puberty
    • Delayed Puberty
    • Puberty
    • Central precocious puberty
    • Precocious puberty
    • Puberty at a young age
    • Late puberty
    • Slow puberty development

    ICD-10 Codes:

    • E301: Precocious puberty
    • E300: Delayed puberty

    Also known as:

    • Underactive Pituitary Gland
    • Pituitary Disorder
    • Combined pituitary hormone deficiency
    • Isolated growth hormone deficiency
    • Hypopituitarism
    • Pituitary Hormone Deficiency
    • Low Pituitary Function

    ICD-10 Codes:

    • E230: Hypopituitarism

    Also known as:

    • Hashimoto's Disease
    • Thyroid Disease
    • Hashimoto's disease
    • Autoimmune thyroiditis', 'Chronic lymphocytic thyroiditis', 'Hashimoto's thyroiditis

    ICD-10 Codes:

    • E063: Autoimmune thyroiditis

    Also known as:

    • Graves' Disease
    • Hyperthyroidism
    • Graves' disease
    • Graves Disease
    • Hyperthyroidism with Goiter
    • Toxic Diffuse Goiter
    • Overactive Thyroid with Enlarged Gland

    ICD-10 Codes:

    • E0500: Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm

    Also known as:

    • Osteogenesis Imperfecta
    • Dentinogenesis imperfecta
    • Brittle bone disease
    • OI
    • Fragile bones

    ICD-10 Codes:

    • Q780: Osteogenesis imperfecta

    Also known as:

    • Other Specific Abnormal Blood Chemistry Results
    • Blood
    • Specified Blood Chemistry Imbalance
    • Unusual Blood Chemistry Findings
    • Specific Blood Panel Abnormalities

    ICD-10 Codes:

    • R7989: Other specified abnormal findings of blood chemistry

    Also known as:

    • Duchenne or Becker Muscular Dystrophy
    • Muscular Dystrophy
    • DMD
    • BMD
    • Duchenne Muscular Dystrophy
    • Becker Muscular Dystrophy

    ICD-10 Codes:

    • G7101: Duchenne or Becker muscular dystrophy

    Also known as:

    • Adrenal Gland Overactivity
    • Adrenal Gland Disorder
    • Adrenocortical Hyperfunction
    • Excess Adrenal Hormones
    • Adrenal Hyperactivity

    ICD-10 Codes:

    • E270: Other adrenocortical overactivity

    Also known as:

    • Turner Syndrome
    • Monosomy X
    • 45,X Karyotype
    • Ullrich-Turner Syndrome

    ICD-10 Codes:

    • Q969: Turner's syndrome, unspecified

    Also known as:

    • Amenorrhea
    • Menstruation
    • Absent Periods
    • No Periods
    • Lack of Menstruation

    ICD-10 Codes:

    • N912: Amenorrhea, unspecified

    Also known as:

    • Multiple Injury
    • Many injuries
    • Several injuries
    • Polytrauma

    ICD-10 Codes:

    • T07XXXA: Unspecified multiple injuries, initial encounter

    Also known as:

    • Child Development Problems
    • Child Development
    • Developmental concerns in children
    • Abnormal child development
    • Lack of normal development

    ICD-10 Codes:

    • R6250: Unspecified lack of expected normal physiological development in childhood

    Also known as:

    • Other Forms of Osteoporosis
    • Osteoporosis
    • Secondary Osteoporosis
    • Bone Thinning Disease

    ICD-10 Codes:

    • M818: Other osteoporosis without current pathological fracture

    Also known as:

    • Down Syndrome
    • Trisomy 21
    • Mongolism

    ICD-10 Codes:

    • Q909: Down syndrome, unspecified

    Does Dr. Bachrach accept my insurance?

    Dr. Bachrach accepts most major insurance plans. Important: Please call our office at (408) 885-5000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Bachrach accept in Palo Alto, CA?

    Dr. Bachrach in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Shield of California

    • California Water Service Group

    • Central California Alliance for Health

    • CVS Health (formerly Aetna)

    • Express Scripts

    • Health Plan of San Mateo

    • OptumRx

    • Santa Clara Family Health Plan

    • UnitedHealthcare

    View All Insurances

    Where is Dr. Bachrach's office located?

    Dr. Laura Bachrach's Primary Practice

    725 Welch Rd

    Palo Alto, CA 94304

    (408) 885-5000

    Get Directions

    Dr. Laura Bachrach's Practice 2

    751 S Bascom Ave

    San Jose, CA 95128

    Get Directions

    Recognitions

    Publications

    Cost-effectiveness of Universal Serologic Screening to Prevent Nontraumatic Hip

    Clinical gastroenterology and hepatology, 2013

    Correlates of low bone mass in children with generalized forms of epidermolysis bullosa

    JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011

    Patterns of bone mineral acquisition in children with epidermolysis bullosa: a longitudil study

    BRITISH JOURL OF DERMATOLOGY, 2011

    Characterization of low bone mass in young patients with thalassemia by DXA

    BONE, 2011

    Biopsychosocial variables associated with substantial bone mineral density loss during the use of

    CONTRACEPTION, 2010

    Idequate Vitamin D Status in Adolescents with Substantial Bone Mineral Density

    JOURL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2010

    Nutritiol Factors That Influence Change in Bone Density

    PM&R, 2010

    Recovery of bone mineral density

    CONTRACEPTION, 2010

    Nutritiol Factors that Influence Change in Bone Density

    NUTRITIOL INFLUENCES ON BONE HEALTH, 2010

    Intertiol longitudil pediatric reference standards for bone mineral content

    BONE, 2010

    Clinical Review: Bisphosphote Use in Childhood Osteoporosis

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009

    Effect of oral contraceptives on weight and body composition in young female runners

    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008

    Longitudil study of depot medroxyprogesterone acetate (Depo

    CONTRACEPTION, 2008

    Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents

    JOURL OF CLINICAL DENSITOMETRY, 2008

    Risk factors for stress fracture among young female cross-country runners

    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2007

    Consensus and controversy regarding osteoporosis in the pediatric population.

    Endocrine practice, 2007

    The effect of oral contraceptives on bone mass and stress fractures in female runners

    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2007

    Bone mineral density in postmerchal adolescent girls in the United States

    Harel, Z., Gold, M., Cromer, B., Bruner, A., Stager, M., Bachrach, L.,, 2007

    Variable deficits of bone mineral despite chronic glucocorticoid therapy

    JOURL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006

    Sequential comparisons of one-month

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006

    Measuring bone mass in children: Can we really do it?

    HORMONE RESEARCH, 2006

    The relative contributions of lean tissue mass and fat mass to bone density in young women

    BONE, 2005

    Osteoporosis and measurement of bone mass in children and adolescents

    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2005

    Consensus statement: Guide to bone health and disease in cystic fibrosis

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005

    Assessing bone health in children: who to test and what does it mean?

    Pediatric endocrinology reviews : PER, 2005

    Taking steps towards reducing osteoporosis in Duchenne Muscular Dystrophy

    NEUROMUSCULAR DISORDERS, 2005

    Official positions of the Intertiol Society for Clinical Densitometry

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004

    Bone health in children and adolescents

    Current problems in pediatric and adolescent health care, 2004

    Standards and guidelines for performing central dual-energy X

    JOURL OF CLINICAL DENSITOMETRY, 2004

    Bone mineral density in pediatric transplant recipients

    TRANSPLANTATION, 2003

    Low-dose intravenous pamidrote reduces fractures in childhood osteoporosis

    JOURL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003

    Disordered eating, menstrual irregularity, and bone mineral density in female runners

    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003

    Comparison of calcaneus ultrasound and dual X-ray absorptiometry in children at risk of osteopenia

    JOURL OF CLINICAL DENSITOMETRY, 2003

    Diet in midpuberty and sedentary activity in prepuberty predict peak bone mass

    AMERICAN JOURL OF CLINICAL NUTRITION, 2003

    Ethnic differences in bone mass of young women vary with method of assessment

    JOURL OF CLINICAL DENSITOMETRY, 2002

    Calcaneus ultrasound measurements in a convenience sample of healthy youth

    JOURL OF CLINICAL DENSITOMETRY, 2001

    Acquisition of optimal bane mass in childhood and adolescence

    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001

    Depot medroxyprogesterone acetate in teens: A risk for bone health?

    PEDIATRICS, 2000

    Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition

    Bachrach, L. K., 2000

    Use of hormone replacement therapy to reduce the risk of osteopenia

    JOURL OF ADOLESCENT HEALTH, 2000

    Mechanobiology of femoral neck structure during adolescence

    JOURL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2000

    Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: A longitudil study

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999

    tural history of growth hormone receptor deficiency

    ACTA PAEDIATRICA, 1999

    A comparison of calcaneus ultrasound

    JOURL OF CLINICAL DENSITOMETRY, 1999

    Influence of pre-adolescent diet on quantitative ultrasound measurements of the calcaneus in young

    OSTEOPOROSIS INTERTIOL, 1999

    Two measures of physical activity as predictors of bone mass in a young cohort

    CLINICAL JOURL OF SPORT MEDICINE, 1998

    Bone acquisition and loss in children and adults with cystic fibrosis: A longitudil study

    JOURL OF PEDIATRICS, 1998

    Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths

    JOURL OF BONE AND MINERAL RESEARCH, 1997

    Intakes of nutrients and foods relevant to bone health in ethnically diverse youths

    JOURL OF THE AMERICAN DIETETIC ASSOCIATION, 1997

    Determints of femoral neck structure during adolescence.

    VANDERMEULEN, M. C., Moro, M., Kiratli, B. J., Marcus, R., Bachrach, L, 1997

    Velocardiofacial syndrome presenting as hypocalcemia in early adolescence

    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1997

    Correspondence between theoretical models

    JOURL OF ORTHOPAEDIC RESEARCH, 1997

    Body mass is the primary determint of midfemoral bone acquisition during adolescent growth

    BONE, 1996

    Differences in bone mineral in young Asian

    JOURL OF BONE AND MINERAL RESEARCH, 1996

    Determints of femoral geometry and structure during adolescent growth

    JOURL OF ORTHOPAEDIC RESEARCH, 1996

    Correlates of osteopenia in patients with cystic fibrosis

    PEDIATRICS, 1996

    Validity of the body mass index as an indicator of adiposity

    AMERICAN JOURL OF HUMAN BIOLOGY, 1996

    BONE-MINERAL DENSITY DURING TREATMENT OF CENTRAL PRECOCIOUS PUBERTY

    JOURL OF PEDIATRICS, 1995

    THE BONE-MINERAL STATUS OF PATIENTS WITH MARFAN-SYNDROME

    JOURL OF BONE AND MINERAL RESEARCH, 1995

    A PHYSICIAN SURVEY OF THERAPY FOR EXERCISE-ASSOCIATED AMENORRHEA - A BRIEF REPORT

    CLINICAL JOURL OF SPORT MEDICINE, 1995

    LOADING FROM BODY-MASS DETERMINES BONE MASS AND STRUCTURE DURING ADOLESCENCE

    VANDERMEULEN, M. C., Moro, M., Kiratli, B. J., Bachrach, L. K., Carter, 1995

    Osteopenia in Turner girls

    TURNER SYNDROME IN A LIFE-SPAN PERSPECTIVE: RESEARCH AND CLINICAL ASPE, 1995

    OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS

    AMERICAN JOURL OF MEDICINE, 1994

    LOW BONE-MINERAL DENSITY AT AXIAL AND APPENDICULAR SITES IN AMENORRHEIC ATHLETES

    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1993

    TURNER SYNDROME ADOLESCENTS RECEIVING GROWTH-HORMONE ARE NOT OSTEOPENIC

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993

    2-YEAR RESULTS OF TREATMENT WITH DEPOT LEUPROLIDE ACETATE FOR CENTRAL PRECOCIOUS PUBERTY

    JOURL OF PEDIATRICS, 1992

    CLINICAL AND ANTHROPOMETRIC CORRELATES OF BONE-MINERAL ACQUISITION IN HEALTHY ADOLESCENT GIRLS

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991

    RECOVERY FROM OSTEOPENIA IN ADOLESCENT GIRLS WITH ANOREXIA-NERVOSA

    JOURL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991

    Thyrotropin inhibits while insulin

    Growth factors, 1991

    DECREASED BONE-DENSITY IN ADOLESCENT GIRLS WITH ANOREXIA-NERVOSA

    PEDIATRICS, 1990

    Interaction of TSH, insulin and insulin

    Growth factors, 1990

    INDUCTION OF ORNITHINE DECARBOXYLASE ACTIVITY BY GROWTH AND DIFFERENTIATION FACTORS IN FRTL-5 CELLS

    YALE JOURL OF BIOLOGY AND MEDICINE, 1989

    REGULATION OF THYROPEROXIDASE, THYROGLOBULIN AND IODIDE LEVELS IN SHEEP THYROID-CELLS BY TSH

    BIOCHIMIE, 1989

    EFFECTS OF AMIODARONE DURING PREGNCY

    CADIAN MEDICAL ASSOCIATION JOURL, 1987

    Role of non-TSH factors in thyroid cell growth.

    Acta endocrinologica. Supplementum, 1987

    ROLE OF NON-TSH FACTORS IN THYROID CELL-GROWTH

    ACTA ENDOCRINOLOGICA, 1987

    DISPARATE UPTAKE OF (TCO4)-TC-99M AND I-125 IN THYROID-CELLS IN CULTURE

    HORMONE AND METABOLIC RESEARCH, 1986

    PHORBOL ESTERS STIMULATE GROWTH AND INHIBIT DIFFERENTIATION IN CULTURED THYROID-CELLS

    ENDOCRINOLOGY, 1985

    THE EFFECTS OF GROWTH-FACTORS AND SERUM ON D

    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1984

    TRANS-PLACENTAL EFFECTS OF 3

    ENDOCRINOLOGY, 1983

    TREATMENT OF OVINE CRETINISM INUTERO WITH 3,5-DIMETHYL-3'-ISOPROPYL-L-THYRONINE

    ENDOCRINOLOGY, 1982

    What is Dr. Bachrach's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Bachrach's National Provider Identifier (NPI) number is 1679550859.

    What common questions do patients ask about Dr. Bachrach?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Bachrach

    What is Dr. Laura Bachrach's specialty?

    Dr. Bachrach is a Pediatric Endocrinologist near Palo Alto, CA. A pediatrician specializing in the care of infants, children, and adolescents with diseases caused by abnormalities in the endocrine glands, which produce hormones. This includes conditions such as diabetes mellitus, growth failure, atypical body size for age, early or delayed puberty, congenital abnormalities, and disorders affecting the thyroid, adrenal, and pituitary glands, as well as the genital region. Contact Dr. Bachrach to book an appointment today.

    Is this Dr. Laura Bachrach affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Bachrach is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Pediatric Endocrinologist?

    Explore Pediatric Endocrinologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Laura Bachrach accepting new patients in Palo Alto, CA?

    Yes, Dr. Laura Bachrach is accepting new patients at this time.

    Does Dr. Laura Bachrach offer online booking?

    Please contact Dr. Bachrach's office at (408) 885-5000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Laura Bachrach?

    Please contact Dr. Bachrach's office at (408) 885-5000 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Laura Bachrach have?

    Dr. Laura Bachrach is certified by the American Board of Pediatrics.

    Other Pediatric Endocrinologist Near Palo Alto, CA

    LV

    Pediatric Endocrinologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    HC

    Pediatric Endocrinologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    Dr. Caroline Buckway, MD

    Pediatric Endocrinologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    See All Specialists

    Doctors by Category

    Specialists